These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2952733)
41. Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity. Moqbel R; Richerson HB; MacDonald AJ; Walsh GM; Hartnell A; Walport MJ; Kay AB Clin Exp Immunol; 1987 Sep; 69(3):676-86. PubMed ID: 2959415 [TBL] [Abstract][Full Text] [Related]
42. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Lucisano Valim YM; Lachmann PJ Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767 [TBL] [Abstract][Full Text] [Related]
43. No quantitative relationship between CR1 and Lutheran expression on erythrocytes: In(Lu) gene product is not a common regulator of CR1 expression on erythrocytes. Oudin S; Lepennec PY; Dervillez X; Tonye-Libyh M; Tabary T; Philbert F; Bougy F; Reveil B; Pennaforte JL; Rouger P; Cohen JH Exp Clin Immunogenet; 1999; 16(2):72-80. PubMed ID: 10343158 [TBL] [Abstract][Full Text] [Related]
45. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915 [TBL] [Abstract][Full Text] [Related]
46. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes. Emlen W; Carl V; Burdick G Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769 [TBL] [Abstract][Full Text] [Related]
47. The inhibition of CR1 mobilization of human granulocytes by the presence of erythrocytes. A possible mechanism for intravascular regulation of granulocyte modulation. Forslid J; Halldén G; Hed J Immunology; 1991 Dec; 74(4):685-8. PubMed ID: 1838355 [TBL] [Abstract][Full Text] [Related]
48. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation. Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731 [TBL] [Abstract][Full Text] [Related]
49. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis. Thomsen BS; Heilmann C; Jacobsen SE; Pedersen FK; Morling N; Jakobsen BK; Svejgaard A; Nielsen H Arthritis Rheum; 1987 Sep; 30(9):967-71. PubMed ID: 2959290 [TBL] [Abstract][Full Text] [Related]
51. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients. Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901 [TBL] [Abstract][Full Text] [Related]
52. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms. Moldenhauer F; Botto M; Walport MJ Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464 [TBL] [Abstract][Full Text] [Related]
53. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome. Thomsen BS; Oxholm P; Nielsen H; Manthorpe R Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207 [TBL] [Abstract][Full Text] [Related]
54. Quantitative analysis of Lewis antigens on erythrocytes by flow cytometry. Murai J; Naka K; Shimojo N; Katakami T; Nakagishi M; Kuroki T; Okuda K Clin Chim Acta; 1994 Apr; 226(1):21-8. PubMed ID: 8070132 [TBL] [Abstract][Full Text] [Related]
55. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783 [TBL] [Abstract][Full Text] [Related]
56. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation]. Pascual M; Schifferli JA Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946 [TBL] [Abstract][Full Text] [Related]
57. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions. Ng YC; Schifferli JA; Walport MJ Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204 [TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205 [TBL] [Abstract][Full Text] [Related]
59. Correction of cellular autofluorescence in flow cytometry by mathematical modeling of cellular fluorescence. Corsetti JP; Sotirchos SV; Cox C; Cowles JW; Leary JF; Blumburg N Cytometry; 1988 Nov; 9(6):539-47. PubMed ID: 3208620 [TBL] [Abstract][Full Text] [Related]
60. Avidin- or streptavidin-biotin as a highly sensitive method to stain total protein on membranes. Santora KE; Nelson SA; Lewis KA; LaRochelle WJ Mol Biotechnol; 2000 Jun; 15(2):161-5. PubMed ID: 10949830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]